NSCI — Netscientific Income Statement
0.000.00%
Last trade - 00:00
- £15.09m
- £16.56m
- £1.00m
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.245 | 0.735 | 0.394 | 1.11 | 1 |
Cost of Revenue | |||||
Gross Profit | 0.167 | 0.618 | 0.348 | 0.989 | 0.782 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 4.35 | 4.37 | 2.86 | 4.07 | 4.75 |
Operating Profit | -4.11 | -3.63 | -2.46 | -2.96 | -3.75 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -4.07 | -3.63 | -2.38 | -2.92 | -3.71 |
Provision for Income Taxes | |||||
Net Income After Taxes | -4 | -3.55 | -2.34 | -2.86 | -3.67 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -8.33 | -4.49 | -1.61 | -2.38 | -3.09 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -8.33 | -4.49 | -1.61 | -2.38 | -3.09 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.326 | -0.389 | -0.027 | -0.13 | -0.136 |